Drawing for CELL TECHNA GENE THERAPY

USPTO serial 79301167

CELL TECHNA GENE THERAPY

Reviewed by CopyMark Law Group

Reg. 6610212Status 700Registered
Filing date
Status date
Registration date
Jan 11, 2022
Examiner
LIEBL, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELL TECHNA GENE THERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19ACTIVE
042Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; scientific laboratory services; technological consultation in the field of development of manufacturing processes for biotechnology productsACTIVE
044Medical services; midwife services; alternative medicine services; in vitro fertilization services; chiropractic services; physiotherapy; occupational therapy services; human tissue bank services; hospital services; rental of medical equipment; medical advice for individuals with disabilities; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; opticians' services; plastic surgery; services of a psychologist; convalescent home services; preparation of prescriptions by pharmacists; rehabilitation of substance abuse patients; nursing, medical; health centre services; health counselling; medical screening; health care; telemedicine servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2022FIMPFINAL DISPOSITION PROCESSED
Apr 11, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2021XAECEXAMINER'S AMENDMENT ENTERED
Sep 20, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Sep 20, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 15, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 14, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 14, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 14, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 14, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 16, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
May 18, 2021CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 16, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Apr 13, 2021RFNTREFUSAL PROCESSED BY IB
Mar 22, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 22, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 18, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2021DOCKASSIGNED TO EXAMINER
Jan 6, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance